The biochemical markers AST, ALT, bilirubin, prothrombin time and MCV were higher and platelets lower in the AFLD group compared to the NAFLD group at the time of index liver biopsy whereas other biochemical markers were similar in the two groups (Table 1). At the end of follow-up, ALT, AST and MCV were the only biochemical markers still significantly higher in the AFLD group compared to the NAFLD group (Table 1). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.